NuCana plc Secures $50M Sales Agreement

Ticker: NCNA · Form: 6-K · Filed: Jun 30, 2025 · CIK: 1709626

Nucana PLC 6-K Filing Summary
FieldDetail
CompanyNucana PLC (NCNA)
Form Type6-K
Filed DateJun 30, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: financing, at-the-market, sales-agreement

TL;DR

NuCana just inked a deal to sell up to $50M in stock via A.G.P. and Laidlaw.

AI Summary

On June 27, 2025, NuCana plc entered into a Sales Agreement with A.G.P./Alliance Global Partners and Laidlaw & Company (UK) Ltd. This agreement allows NuCana to potentially sell up to $50 million of its ordinary shares from time to time through the agents.

Why It Matters

This agreement provides NuCana with a flexible way to raise capital, which could be used for ongoing research and development or to fund future clinical trials.

Risk Assessment

Risk Level: medium — The company is raising capital through stock sales, which can dilute existing shareholders and is subject to market conditions.

Key Numbers

  • $50.0M — Potential Capital Raise (Maximum amount NuCana plc can raise through the Sales Agreement)

Key Players & Entities

  • NuCana plc (company) — Registrant
  • A.G.P./Alliance Global Partners (company) — Agent in Sales Agreement
  • Laidlaw & Company (UK) Ltd (company) — Agent in Sales Agreement
  • $50 million (dollar_amount) — Maximum amount of ordinary shares that can be sold
  • June 27, 2025 (date) — Date the Sales Agreement was entered into

FAQ

What is the purpose of the Sales Agreement entered into by NuCana plc?

The Sales Agreement allows NuCana plc to sell up to $50 million of its ordinary shares from time to time through A.G.P./Alliance Global Partners and Laidlaw & Company (UK) Ltd.

Who are the agents involved in NuCana's Sales Agreement?

The agents involved are A.G.P./Alliance Global Partners and Laidlaw & Company (UK) Ltd.

What is the maximum amount NuCana plc can raise under this Sales Agreement?

NuCana plc can raise up to $50 million under the terms of the Sales Agreement.

When was the Sales Agreement entered into?

The Sales Agreement was entered into on June 27, 2025.

What type of securities can be sold under the Sales Agreement?

Ordinary shares of NuCana plc can be sold under the Sales Agreement.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on June 30, 2025 regarding NuCana plc (NCNA).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.